JDRF: ViaCyte to File Investigational New Drug Application

In a release, the organization noted the trial would evaluate the safety and efficacy of the VC-01 product candidate, a stem cell- derived, encapsulated cell replacement therapy.

http://ift.tt/1sIGLec